Lecture

Anticancer Therapies I: De Palma

Description

This lecture discusses the decline of cancer death rates due to improved diagnostic tools, health conditions, and habits rather than better therapies. It covers conventional and targeted anticancer drugs, surgical oncology principles, radiotherapy history, resistance mechanisms, chemotherapy principles and history, types of chemotherapy, and resistance mechanisms. The lecture also explores the history of the first targeted drug, the efficacy of Gleevec in CML, targeting EGFR in NSCLC, specific mutations in EGFR, and the concept of synthetic lethality in cancer treatment.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.